Digital Home-Based Prehabilitation Before Surgery
Launched by VESTRE VIKEN HOSPITAL TRUST · Jan 26, 2024
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different prehabilitation programs can help patients prepare for major colorectal cancer surgery. Prehabilitation refers to the activities and support offered before surgery to improve a patient's strength and overall health. In this trial, one group will receive a program that includes guided physical exercise, nutritional support, help with quitting smoking, and adjustments to their medications, while the other group will not have any structured prehabilitation.
To be eligible for this trial, participants must be planning to have major gastrointestinal cancer surgery, speak and understand Norwegian, and be able to complete questionnaires. However, individuals who cannot walk for six minutes, have certain heart or lung conditions, or live too far from the hospital may not qualify. Participants can expect to be involved in a supportive program aimed at helping them be as healthy as possible before their surgery, which may lead to better recovery outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Planned for major gastrointestinal cancer surgery
- • Fluent in Norwegian and able to consent and to understand questionnaires
- Exclusion Criteria:
- • Inability to walk for six minutes or to rise independently from a chair
- • Inability to comprehend exercise program or to comply with written and oral instructions
- • Presence of a cardio-pulmonary condition that precludes exercise
- • Living in very remote areas making a hospital-based intervention group impossible to implement
- • Being without a permanent address
- • Admittance to a hospital facility for \> 50% of the time from diagnosis to surgery
About Vestre Viken Hospital Trust
Vestre Viken Hospital Trust is a prominent healthcare institution in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a leading sponsor of clinical trials, Vestre Viken focuses on innovative healthcare solutions that enhance patient outcomes and contribute to scientific knowledge. The trust collaborates with various stakeholders, including academic institutions and industry partners, to facilitate rigorous research initiatives across multiple therapeutic areas. Committed to ethical standards and patient safety, Vestre Viken aims to foster an environment that promotes cutting-edge medical advancements and improves healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Rune Ougland, MD PhD
Principal Investigator
Vestre Viken, Bærum Hospital, Norway
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported